DJIA 17,879.59 -96.72 -0.54%
NASDAQ 4,925.80 -21.64 -0.44%
S&P 500 2,077.16 -9.08 -0.44%
market minute promo

Abbott Laboratories (NYSE: ABT)

46.72 -0.36 (-0.76%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABT $46.72 -0.76%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.83
Previous Close $47.08
Daily Range $46.58 - $46.98
52-Week Range $36.65 - $47.88
Market Cap $70.5B
P/E Ratio 42.04
Dividend (Yield) $0.96 (2.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,631,053
Average Daily Volume 5,261,475
Current FY EPS $2.15




Drug Makers

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website:

News & Commentary

The Single Worst Practice of the Drug Industry

Pay for delay is a legal maneuver Big Pharma uses to keep generic drugs off the market. According to the FTC, it costs consumers and taxpayers $3.5 billion every year.

Today's Market: Healthcare, Technology Mergers And Acquisitions Boosting These Stocks

The Best Stocks To Buy This Week

Dividend Achievers Top 20 Hits The Mark, Again

The Philosopher Series, Part XV: What Would Bacon Invest In Today?

Mylan Is One Of The Most Undervalued Generic Companies

Sucampo Pharmaceuticals Revamp Impresses Wall Street

The Best Stocks To Buy This Week

Abbott Laboratories: Dividend Stock Analysis

Insider Trading Alert - SF, SJI And ABT Traded By Insiders

See More ABT News...

ABT's Top Competitors

ABT $46.72 (-0.76%)
Current stock: ABT
JNJ $100.97 (-0.57%)
Current stock: JNJ
NVS $98.86 (-2.42%)
Current stock: NVS
RHHBY $34.41 (0.58%)
Current stock: RHHBY